Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Owen CG, Fletcher AE, Donoghue M, Rudnicka AR. How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom? Br J Ophthalmol 2003; 87: 312–317.
2. Kanski JJ, Bowling B . Age-related macular degeneration. In JJ Kanski, B Bowling (eds) Clinical Ophthalmology: A Systematic Approach 7th ed Saunders: London, 2011, 611–616.
3. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995; 39 (5): 367–374.
4. Mitchell P, Korobelnik JF, Lanzetta P, Holz FG, Prunte C, Schmidt-Erfurth U et al. Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials. Br J Ophthalmol 2010; 94: 2–13.
5. Evans J, Wormald R . Is the incidence of registrable age-related macular degeneration increasing? Br J Ophthalmol 1996; 80: 9–14.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献